Outcomes of STN-DBS in PD Patients With Different Rates of Disease Progression Over One Year of Follow-Up
Authors:
Open Access
- 24 July 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 11, 600
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder, and the rate of progression is different across individuals. Subthalamic nucleus deep brain stimulation (STN-DBS) has been shown to produce long-term symptom improvement in PD. In this retrospective study, we wanted to explore the effects of bilateral STN-DBS in PD patients with different rates of disease progression. Forty patients with PD were included. An index of progression rate was calculated by the ratio of the Unified Parkinson Disease Rating Scale, part III (UPDRS-III), score in the off-medication condition at baseline and disease duration. The patients were divided into fast-, medium-, and slow-progression groups by this index. The outcome measurements at the 1st, 6th, and 12th months after surgery were the changes in UPDRS-III scores in the off-medication/on-stimulation condition compared with the baseline. We found the following. (1). Motor functions in the different PD progression groups were improved by bilateral STN-DBS treatment at 1 year of follow-up. (2). However, compared to the slow- and medium-progression groups, the fast-progression group had less improvement at the 6th- and 12th-month follow-up. The results indicated that bilateral STN-DBS can improve motor functions of Parkinson's patients over the 1-year follow-up. Moreover, the outcomes in the slow- and medium-progression patients were better than those with fast-progression rates.Keywords
This publication has 26 references indexed in Scilit:
- Long‐term outcomes of surgical therapies for Parkinson's diseaseMovement Disorders, 2012
- Parkinson's Disease and Parkinsonism: NeuropathologyCold Spring Harbor Perspectives in Medicine, 2012
- Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's diseaseMovement Disorders, 2011
- Systematic review of levodopa dose equivalency reporting in Parkinson's diseaseMovement Disorders, 2010
- Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's diseaseMovement Disorders, 2010
- Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodiesJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Test–retest reliability of UPDRS‐III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: An argument against multiple baseline assessmentsMovement Disorders, 2004
- Parkinson's disease‐like presentation of multiple system atrophy with poor response to STN stimulation: A clinicopathological case reportMovement Disorders, 2004
- Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's diseaseMovement Disorders, 2002
- Effect of age and disease duration on parkinsonian motor scores under levodopa therapyJournal of Neural Transmission, 1995